<p>WINTON GROUP Ltd 在最近向美国证券交易委员会提交的 13F 文件中披露，在第四季度购买了 Oscar Health, Inc.（纽约证券交易所代码：OSCR - 免费报告）的新股份。该公司购买了 146,030 股，价值约为 2,098,000 美元。WINTON GROUP Ltd 在最近的报告期末持有 Oscar Health 约 0.06% 的股份。</p>
<ul>
<li>5 只小盘股具有爆炸性上涨潜力</li>
</ul>
<p>其他几家机构投资者和对冲基金也买卖了 OSCR 的股份。Jones Financial Companies Lllp 在第一季度将其在 Oscar Health 的持仓增加了 7,473.3%。Jones Financial Companies Lllp 现在拥有 2,272 股该公司的股票，价值 30,000 美元，此前在上个季度额外购买了 2,242 股。Strs Ohio 在第一季度购买了价值约 30,000 美元的 Oscar Health 新股份。Fifth Third Bancorp 在第四季度将其在 Oscar Health 的持仓增加了 148.7%。Fifth Third Bancorp 现在拥有 2,363 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,413 股。Quarry LP 在第三季度将其在 Oscar Health 的持仓增加了 439.8%。Quarry LP 现在拥有 1,803 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,469 股。最后，Binnacle Investments Inc 在第二季度购买了价值约 75,000 美元的 Oscar Health 新股份。目前，75.70% 的股票由机构投资者持有。</p>
<h2>分析师评级上调与下调</h2>
<p>一些股票研究分析师最近对该公司发表了看法。富国银行设定了 Oscar Health 的目标价为 20.00 美元，并在周四的研究报告中给予该股票 “持平” 评级。Robert W. Baird 将 Oscar Health 的目标价从 15.00 美元上调至 19.00 美元，并在周四的研究报告中给予该股票 “中性” 评级。Jefferies Financial Group 将 Oscar Health 的评级从 “表现不佳” 上调至 “持有”，并在 4 月 20 日的研究报告中将该股票的目标价从 10.00 美元上调至 16.00 美元。瑞银集团将 Oscar Health 的目标价从 15.00 美元上调至 20.00 美元，并在周四的研究报告中给予该股票 “中性” 评级。最后，巴克莱将 Oscar Health 的目标价从 21.00 美元上调至 30.00 美元，并在周二的研究报告中给予该股票 “持平” 评级。一位研究分析师给予该股票 “强烈买入” 评级，两位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，平均目标价为 20.22 美元。</p>
<p><strong>获取我们关于 OSCR 的最新报告</strong></p>
<h2>Oscar Health 股价上涨 0.3%</h2>
<p>OSCR 周一开盘价为 24.59 美元。该股票的市值为 74.1 亿美元，市盈率为 -41.68，市盈增长比率为 1.71，贝塔值为 2.37。该公司的速动比率为 1.11，流动比率为 1.11，债务与股本比率为 0.26。该业务的 50 日移动平均线为 18.39 美元，200 日移动平均线为 16.07 美元。Oscar Health, Inc. 的 52 周最低价为 10.69 美元，52 周最高价为 25.58 美元。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近于 5 月 6 日发布了其财报。该公司报告季度每股收益为 2.07 美元，超出分析师一致预期的 1.11 美元，超出幅度为 0.96 美元。该季度的收入为 46.5 亿美元，而分析师预期为 49 亿美元。Oscar Health 的股本回报率为 -3.26%，净利润率为 -0.30%。该公司的季度收入同比增长 52.6%。去年同期，该公司每股收益为 0.92 美元。股票研究分析师预测，Oscar Health, Inc. 在当前财年将发布 0.47 美元的每股收益。</p>
<h2>影响 Oscar Health 的关键头条</h2>
<p>以下是本周影响 Oscar Health 的关键新闻：</p>
<ul>
<li>积极情绪：富国银行将 Oscar Health 的评级从 <strong>“强烈卖出” 上调至 “持有”</strong>，尽管其 20 美元的目标价仍低于当前股价，缓解了看空情绪。Zacks.com</li>
<li>积极情绪：Oscar Health 最近的财报显示 <strong>大幅超出每股收益预期</strong>，尽管收入低于预期，但支持了该股票的基本面故事。</li>
<li>中性情绪：一位公司联合创始人转任 <strong>顾问领导角色</strong>，看起来像是内部重组，而不是颠覆性变化。Oscar Health 联合创始人转任顾问领导角色</li>
<li>中性情绪：多位内部人士，包括 <strong>首席财务官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，在预先计划的 10b5-1 计划下出售股份，以覆盖已归属股权奖励的税务义务，这比自愿出售的担忧要小。</li>
<li>消极情绪：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，这是最新一批内部人士出售中最大的一笔，尽管是预先安排的，但可能会对市场情绪造成压力。</li>
</ul>
<h2>内部人士买卖情况</h2>
<p>在其他新闻中，内部人士亚当·麦克纳尼（Adam Mcananey）于 6 月 2 日星期二出售了 9,859 股公司的股票。股票以平均价格 21.94 美元出售，总价值为 216,306.46 美元。交易完成后，该内部人士在公司持有 218,096 股，价值为 4,785,026.24 美元。这笔交易代表其持股减少了 4.32%。该交易在向美国证券交易委员会（SEC）提交的文件中披露，文件可通过此超链接获取。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税款扣缴义务。此外，首席财务官理查德·斯科特·布莱克利（Richard Scott Blackley）于 5 月 14 日星期四出售了 100,000 股公司的股票。这些股票以平均价格 23.16 美元出售，总价值为 2,316,000.00 美元。交易完成后，首席财务官持有 1,216,660 股公司的股票，价值约为 28,177,845.60 美元。这笔交易代表其持股减少了 7.59%。该销售的 SEC 文件提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。内部人士在过去一个季度共出售了 189,660 股公司股票，价值 4,283,140 美元。公司内部人士持有公司 25.11% 的股票。</p>
<h2>Oscar Health 公司简介</h2>
<p>（免费报告）</p>
<p>Oscar Health 在纽约证券交易所以 OSCR 的股票代码交易，是一家以技术驱动的健康保险公司，总部位于纽约。该公司由马里奥·施洛瑟（Mario Schlosser）、约书亚·库什纳（Joshua Kushner）和凯文·纳泽米（Kevin Nazemi）于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
<p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Oscar Health</li>
<li>这三只保险股票创下 52 周新高：还有买入的机会吗？</li>
<li>三只 20 美元以下的股票，值得在更广泛的市场反弹前买入</li>
<li>Petco 面临激烈竞争，但势头正在增强</li>
<li>锁定效应是真实存在的——这三家房屋建筑商正在押注于此</li>
</ul>
<p><strong>想看看其他对 OSCR 感兴趣的对冲基金持有哪些股票？</strong> 请访问 HoldingsChannel.com，获取 Oscar Health, Inc.（纽约证券交易所：OSCR - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场关注之前买入……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

OSCG

OSCX

<p>WINTON GROUP Ltd 在第四季度建立了 210 万美元的 Oscar Health (OSCR) 头寸，根据 SEC 文件购买了 146,030 股。机构持股比例为 75.7%。分析师最近调整了价格目标和评级：富国银行将目标价设定为 20 美元，评级为 “持平”，而瑞士银行将目标价上调至 20 美元。平均分析师评级为 “持有”，目标价为 20.22 美元。Oscar Health 最近报告了第一季度每股收益为 2.07 美元，超出预期，但收入未达标</p>

<p>WINTON GROUP Ltd purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 146,030 shares of the company's stock, valued at approximately $2,098,000. WINTON GROUP Ltd owned about 0.06% of Oscar Health at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>WINTON GROUP Ltd 在最近向美国证券交易委员会提交的 13F 文件中披露，在第四季度购买了 Oscar Health, Inc.（纽约证券交易所代码：OSCR - 免费报告）的新股份。该公司购买了 146,030 股，价值约为 2,098,000 美元。WINTON GROUP Ltd 在最近的报告期末持有 Oscar Health 约 0.06% 的股份。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只小盘股具有爆炸性上涨潜力</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also bought and sold shares of OSCR. Jones Financial Companies Lllp grew its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio bought a new stake in shares of Oscar Health in the 1st quarter worth approximately $30,000. Fifth Third Bancorp grew its position in shares of Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock worth $34,000 after buying an additional 1,413 shares during the last quarter. Quarry LP grew its position in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock worth $34,000 after buying an additional 1,469 shares during the last quarter. Finally, Binnacle Investments Inc bought a new stake in shares of Oscar Health in the 2nd quarter worth approximately $75,000. 75.70% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家机构投资者和对冲基金也买卖了 OSCR 的股份。Jones Financial Companies Lllp 在第一季度将其在 Oscar Health 的持仓增加了 7,473.3%。Jones Financial Companies Lllp 现在拥有 2,272 股该公司的股票，价值 30,000 美元，此前在上个季度额外购买了 2,242 股。Strs Ohio 在第一季度购买了价值约 30,000 美元的 Oscar Health 新股份。Fifth Third Bancorp 在第四季度将其在 Oscar Health 的持仓增加了 148.7%。Fifth Third Bancorp 现在拥有 2,363 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,413 股。Quarry LP 在第三季度将其在 Oscar Health 的持仓增加了 439.8%。Quarry LP 现在拥有 1,803 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 1,469 股。最后，Binnacle Investments Inc 在第二季度购买了价值约 75,000 美元的 Oscar Health 新股份。目前，75.70% 的股票由机构投资者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>A number of equities research analysts have recently weighed in on the company. Wells Fargo &amp; Company set a $20.00 price objective on Oscar Health and gave the stock an &#34;equal weight&#34; rating in a research report on Thursday. Robert W. Baird lifted their price objective on Oscar Health from $15.00 to $19.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded Oscar Health from an &#34;underperform&#34; rating to a &#34;hold&#34; rating and lifted their price objective for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, May 7th. Finally, Barclays lifted their price objective on Oscar Health from $21.00 to $30.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of &#34;Hold&#34; and an average target price of $20.22.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对该公司发表了看法。富国银行设定了 Oscar Health 的目标价为 20.00 美元，并在周四的研究报告中给予该股票 “持平” 评级。Robert W. Baird 将 Oscar Health 的目标价从 15.00 美元上调至 19.00 美元，并在周四的研究报告中给予该股票 “中性” 评级。Jefferies Financial Group 将 Oscar Health 的评级从 “表现不佳” 上调至 “持有”，并在 4 月 20 日的研究报告中将该股票的目标价从 10.00 美元上调至 16.00 美元。瑞银集团将 Oscar Health 的目标价从 15.00 美元上调至 20.00 美元，并在周四的研究报告中给予该股票 “中性” 评级。最后，巴克莱将 Oscar Health 的目标价从 21.00 美元上调至 30.00 美元，并在周二的研究报告中给予该股票 “持平” 评级。一位研究分析师给予该股票 “强烈买入” 评级，两位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的平均评级为 “持有”，平均目标价为 20.22 美元。</p>
</div><p><strong>Get Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 OSCR 的最新报告</strong></p>
</div><h2>Oscar Health Trading Up 0.3%</h2>
<div class="lb-trans"><h2>Oscar Health 股价上涨 0.3%</h2>
</div><p>OSCR opened at $24.59 on Monday. The stock has a market cap of $7.41 billion, a PE ratio of -41.68, a PEG ratio of 1.71 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The business has a 50 day moving average of $18.39 and a 200-day moving average of $16.07. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $25.58.</p>
<div class="lb-trans"><p>OSCR 周一开盘价为 24.59 美元。该股票的市值为 74.1 亿美元，市盈率为 -41.68，市盈增长比率为 1.71，贝塔值为 2.37。该公司的速动比率为 1.11，流动比率为 1.11，债务与股本比率为 0.26。该业务的 50 日移动平均线为 18.39 美元，200 日移动平均线为 16.07 美元。Oscar Health, Inc. 的 52 周最低价为 10.69 美元，52 周最高价为 25.58 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm's revenue for the quarter was up 52.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.92 EPS. Equities research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近于 5 月 6 日发布了其财报。该公司报告季度每股收益为 2.07 美元，超出分析师一致预期的 1.11 美元，超出幅度为 0.96 美元。该季度的收入为 46.5 亿美元，而分析师预期为 49 亿美元。Oscar Health 的股本回报率为 -3.26%，净利润率为 -0.30%。该公司的季度收入同比增长 52.6%。去年同期，该公司每股收益为 0.92 美元。股票研究分析师预测，Oscar Health, Inc. 在当前财年将发布 0.47 美元的每股收益。</p>
</div><h2>Key Headlines Impacting Oscar Health</h2>
<div class="lb-trans"><h2>影响 Oscar Health 的关键头条</h2>
</div><p>Here are the key news stories impacting Oscar Health this week:</p>
<div class="lb-trans"><p>以下是本周影响 Oscar Health 的关键新闻：</p>
</div><ul>
<li>Positive Sentiment: Wells Fargo upgraded Oscar Health from <strong>“strong sell” to “hold”</strong>, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com</li>
<li>Positive Sentiment: Oscar Health’s recent earnings showed a <strong>major EPS beat</strong>, which supports the stock’s fundamental story despite revenue coming in below estimates.</li>
<li>Neutral Sentiment: A company co-founder shifting into an <strong>advisory leadership role</strong> looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role</li>
<li>Neutral Sentiment: Multiple insiders, including <strong>CFO Richard Scott Blackley</strong> and <strong>CAO Victoria Baltrus</strong>, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.</li>
<li>Negative Sentiment: Director <strong>Mario Schlosser</strong> sold <strong>34,120 shares</strong>, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：富国银行将 Oscar Health 的评级从 <strong>“强烈卖出” 上调至 “持有”</strong>，尽管其 20 美元的目标价仍低于当前股价，缓解了看空情绪。Zacks.com</li>
<li>积极情绪：Oscar Health 最近的财报显示 <strong>大幅超出每股收益预期</strong>，尽管收入低于预期，但支持了该股票的基本面故事。</li>
<li>中性情绪：一位公司联合创始人转任 <strong>顾问领导角色</strong>，看起来像是内部重组，而不是颠覆性变化。Oscar Health 联合创始人转任顾问领导角色</li>
<li>中性情绪：多位内部人士，包括 <strong>首席财务官 Richard Scott Blackley</strong> 和 <strong>首席行政官 Victoria Baltrus</strong>，在预先计划的 10b5-1 计划下出售股份，以覆盖已归属股权奖励的税务义务，这比自愿出售的担忧要小。</li>
<li>消极情绪：董事 <strong>Mario Schlosser</strong> 出售了 <strong>34,120 股</strong>，这是最新一批内部人士出售中最大的一笔，尽管是预先安排的，但可能会对市场情绪造成压力。</li>
</ul>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人士买卖情况</h2>
</div><p>In other news, insider Adam Mcananey sold 9,859 shares of the firm's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. This trade represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 100,000 shares of the firm's stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $23.16, for a total value of $2,316,000.00. Following the completion of the transaction, the chief financial officer owned 1,216,660 shares of the company's stock, valued at approximately $28,177,845.60. The trade was a 7.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 189,660 shares of company stock worth $4,283,140 over the last quarter. Company insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，内部人士亚当·麦克纳尼（Adam Mcananey）于 6 月 2 日星期二出售了 9,859 股公司的股票。股票以平均价格 21.94 美元出售，总价值为 216,306.46 美元。交易完成后，该内部人士在公司持有 218,096 股，价值为 4,785,026.24 美元。这笔交易代表其持股减少了 4.32%。该交易在向美国证券交易委员会（SEC）提交的文件中披露，文件可通过此超链接获取。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税款扣缴义务。此外，首席财务官理查德·斯科特·布莱克利（Richard Scott Blackley）于 5 月 14 日星期四出售了 100,000 股公司的股票。这些股票以平均价格 23.16 美元出售，总价值为 2,316,000.00 美元。交易完成后，首席财务官持有 1,216,660 股公司的股票，价值约为 28,177,845.60 美元。这笔交易代表其持股减少了 7.59%。该销售的 SEC 文件提供了更多信息。该交易是在预先安排的 10b5-1 交易计划下执行的。内部人士在过去一个季度共出售了 189,660 股公司股票，价值 4,283,140 美元。公司内部人士持有公司 25.11% 的股票。</p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health 在纽约证券交易所以 OSCR 的股票代码交易，是一家以技术驱动的健康保险公司，总部位于纽约。该公司由马里奥·施洛瑟（Mario Schlosser）、约书亚·库什纳（Joshua Kushner）和凯文·纳泽米（Kevin Nazemi）于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?</li>
<li>3 Stocks Under $20 to Buy Before a Broader Market Rally</li>
<li>Petco Faces Tough Competition, But Momentum Is Building</li>
<li>The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Oscar Health</li>
<li>这三只保险股票创下 52 周新高：还有买入的机会吗？</li>
<li>三只 20 美元以下的股票，值得在更广泛的市场反弹前买入</li>
<li>Petco 面临激烈竞争，但势头正在增强</li>
<li>锁定效应是真实存在的——这三家房屋建筑商正在押注于此</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 OSCR 感兴趣的对冲基金持有哪些股票？</strong> 请访问 HoldingsChannel.com，获取 Oscar Health, Inc.（纽约证券交易所：OSCR - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场关注之前买入……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

WINTON GROUP Ltd Takes $2.10 Million Position in Oscar Health, Inc. $OSCR

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

五三银行

富国银行

Jefferies Financial

瑞银集团

巴克莱银行

五三银行-存托优先股Series K

Fifth Third Bancorp Pref Shares FITBM 6.875 Perp 10/01/30

五三银行-Series A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

WINTON GROUP Ltd 在 Oscar Health, Inc. $OSCR 中建立了 210 万美元的头寸